
National Research Corporation NRC
€ 14.99
-0.4%
Geschäftsbericht 2025
hinzugefügt 05.03.2026
Land |
|
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
22.4 M |
Marktkapitalisierung |
$ 387 M |
EBITDA (LTM) |
$ 32.9 M |
P/E (LTM) |
26.55 |
P/S (LTM) |
2.84 |
EPS (LTM) |
0.66 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Biodesix
BDSX
|
$ 14.07 | -3.66 % | $ 1.82 B | Nasdaq Global Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Illumina
ILMN
|
$ 118.71 | -4.57 % | $ 18.9 B | Nasdaq Global Select Market,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.61 | -0.61 % | $ 61.9 M | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 158.87 | -3.79 % | $ 7.87 B | NYSE,SPB | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
ENDRA Life Sciences
NDRA
|
$ 4.7 | 2.4 % | $ 2.52 M | Nasdaq Global Select Market | ||
|
Personalis
PSNL
|
$ 6.58 | -10.11 % | $ 390 M | Nasdaq Global Select Market | ||
|
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.73 | 2.37 % | $ 7.59 M | Nasdaq Global Select Market | ||
|
RadNet
RDNT
|
$ 57.26 | -3.62 % | $ 4.31 B | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Celcuity
CELC
|
$ 111.47 | -2.91 % | $ 5.21 B | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Senseonics Holdings
SENS
|
$ 6.49 | -1.07 % | $ 271 M | NYSE American | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 268.62 | 0.09 % | $ 22.3 B | NYSE,SPB | ||
|
VolitionRx Limited
VNRX
|
$ 0.2 | 1.11 % | $ 19.2 M | NYSE American | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
Bioventus
BVS
|
$ 9.15 | -1.19 % | $ 610 M | Nasdaq Global Select Market | ||
|
Precipio
PRPO
|
$ 26.48 | -2.65 % | $ 34.4 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 17.13 | -1.95 % | $ 913 M | Nasdaq Global Market,SPB | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
Biomerica
BMRA
|
$ 2.04 | -3.55 % | $ 4.69 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 24.01 | -2.79 % | $ 667 M | Nasdaq Global Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 8.45 | - | $ 33.7 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 63.05 | -4.61 % | $ 24.6 B | Nasdaq Global Select Market,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.13 | -1.74 % | $ 6.15 M | Nasdaq Capital Market,SPB |